C100.ST C100 AB

Technology Information Technology Services Stockholm Exchange
3.40 SEK
Close of Nov 4, 2026
2.82 11.60
Market cap
SEK 18.7M
P/E
-
P/B
0.55x
ROE
20.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is C100.ST undervalued?

Graham number

The Graham number of C100 AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

C100 AB fundamental analysis

No fundamental analysis for C100 AB yet.

C100 AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About C100 AB

C100 AB (publ) is public investment firm specializing in early stage, growth stage and emerging stage. The firm prefers to invest in technology and life science sector. It typically focuses on early-stage biotech platforms, emerging digital health technologies, transformative software solutions for the investments. C100 AB (publ) was founded in 2025 and is headquartered in Stockholm, Sweden.

Full company profile